Výpis publikací

ŠIMONÍK, Jan; Petr LAPČÍK; Pavla BOUCHALOVÁ a Pavel BOUCHAL. Data-Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research. Mass Spectrometry Reviews. Wiley, 2026, 33 s. ISSN 0277-7037. Dostupné z: https://doi.org/10.1002/mas.70014.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Lucia JANÁČOVÁ; Alice HLOBILKOVÁ; Kateřina JURÁSKOVÁ; Alexandr POPRACH; Milan HORA; Ondřej FIALA a Pavel BOUCHAL. DIA-MS identified transmembrane glycoprotein GPNMB as a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma. In In book of abstracts of Conference of the European Proteomics Association 2025, Saint-Malo June 16-20, 2025. 2025.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; Kateřina JURÁSKOVÁ; Ingrid KOVÁČOVÁ; David POTĚŠIL; Vojtěch BYSTRÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Integrated multiomics classification of triple negative breast cancer. In In Book of Abstract of 11. Informal Proteomic Meeting and 13. Annual Conference of Czech Society for Mass Spectrometry. České Budějovice, 19.-21.11.2025. 2025. ISBN 978-80-907478-5-2.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; Kateřina JURÁSKOVÁ; David POTĚŠIL; Miloš HOLÁNEK; Vojtěch BYSTRÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Integrated proteogenomic analysis identifies synuclein gamma as a key target of the mesenchymal stem-like subtype of triple negative breast cancer. In In book of abstracts of 13th Conference of Czech Mass Spectrometry together with 11th Informal proteomic meeting, 19-21 2025, České Budějovice. 2025.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; Kateřina JURÁSKOVÁ; Ingrid KOVÁČOVÁ; David POTĚŠIL; Lucia JANÁČOVÁ; Miloš HOLÁNEK; Boris TICHÝ; Vojtěch BYSTRÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Proteomics-driven multi-omics classification of triple negative breast cancer. In In Book of Abstracts of PhD Conference 2025, Brno, Česká republika 29.5. 2025, P16. 2025.

LAPČÍK, Petr; Jan ŠIMONÍK; Pavla BOUCHALOVÁ; Kateřina JURÁSKOVÁ; David POTĚŠIL; Lucia JANÁČOVÁ; Boris TICHÝ; Vojtěch BYSTRÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Breast cancer subclassification based on proteomics/proteogenomics for targeted therapy. In In Book of Abstracts of 19th Czech Annual Cancer Research Meeting, November 18-20, 2024, p. 22-23. 2024.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Kateřina JURÁSKOVÁ; Petr LAPČÍK; David POTĚŠIL; Vojtěch BYSTRÝ; Jiří NAVRÁTIL; Boris TICHÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Proteogenomic Classification of Triple-Negative Breast Cancer for Prognosis and Targeted therapy. In n Book of Abstracts of PhD Conference 2024, Brno, Česká republika 30.5. 2024, P7. 2024.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Lucia JANÁČOVÁ; Alice HLOBILKOVÁ; Kateřina JURÁSKOVÁ; Alexandr POPRACH; Hora MILAN; Fiala ONDŘEJ a Pavel BOUCHAL. Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma. In In Book of Abstracts of 23rd Human Proteome Organization World Congress, Dresden, Germany 20.10.-24.10.2024, P-II-0679, 2024. 2024.

LAPČÍK, Petr; Jan ŠIMONÍK; Pavla BOUCHALOVÁ; Kateřina JURÁSKOVÁ; David POTĚŠIL; Lucia JANÁČOVÁ; Boris TICHÝ; Vojtěch BYSTRÝ; Rudolf NENUTIL; Roman HRSTKA a Pavel BOUCHAL. Understanding breast cancer biology via proteomics, proteogenomics and interactomics to identify novel therapy targets. In In Book of Abstracts of 10. Informal Proteomic Meeting, November 28-29, 2024, Olomouc, p. 17. 2024.

BOUCHALOVÁ, Pavla; Jan ŠIMONÍK; Petr LAPČÍK; Lucia JANÁČOVÁ; David POTĚŠIL; Ján PODHOREC; Alice HLOBILKOVÁ; Vlad POPOVICI; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma. In Abstract Book of EACR Conference: Cellular Bases for Patient Response to Cancer Therapies, Lyon, Francie 14.-16.11.2023, P12. 2023.

ŠIMONÍK, Jan; Richard ŠTEFANÍK; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Vlad POPOVICI; Ján PODHOREC; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response. In Abstract Book of BSRP - EuPA Annual Scientific Meeting, Newcastle upon Tyne, UK, 17.-20.7.2023. 2023.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Richard ŠTEFANÍK; Petr LAPČÍK; David POTĚŠIL; Vlad POPOVICI; Ján PODHOREC; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response. In Abstract Book of XVIII. Czech Annual Cancer Research Meeting, Olomouc, CZ, 20.-22.11.2023. 2023. ISBN 978-80-908348-2-8.

ŠIMONÍK, Jan; Richard ŠTEFANÍK; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. Proteotype classification of renal cell carcinoma for prognosis and therapy response. In Doctoral conference 2023, MUNI, Department of Biochemistry. 2023.

BOUCHAL, Pavel; Jan ŠIMONÍK; Richard ŠTEFANÍK; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Milan HORA; Alexandr POPRACH a Ondřej FIALA. Proteotypová klasifikace renálního karcinomu. In Sborník abstrakt (Klinická onkologie, ročník 36, Supplementum I), XLVII. Brněnské onkologické dny, Brno, CZ, 1.-3.11.2023, XXXI/81. 2023.

ŠIMONÍK, Jan; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Lucia JANÁČOVÁ; Alice HLOBILKOVÁ; Vlad POPOVICI; Alexandr POPRACH; Milan HORA; Ondřej FIALA a Pavel BOUCHAL. Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment. In 9th Informal Proteomic Meeting November 30 – December 1, Mělník, Masaryk Cultural House. 2023.

ŠIMONÍK, Jan; Petr LAPČÍK; Pavla BOUCHALOVÁ; Lucia JANÁČOVÁ; David POTĚŠIL; Ján PODHOREC; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment. In In Book of Abstracts of 14th European Summer School, Brixen, Italy 31.7.-6.8. 2022, p.46. 2022.

BOUCHALOVÁ, Pavla; Jan ŠIMONÍK; David POTĚŠIL; Petr LAPČÍK; Ján PODHOREC; Lucia JANÁČOVÁ; Milan HORA; Alice HLOBILKOVÁ; Alexandr POPRACH; Vlad POPOVICI; Ondřej FIALA a Pavel BOUCHAL. Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory. In Sborník abstrakt, přednášek a posterů, XXV. Biologické dny, Brno 5.- 6.9.2022, p. 40. 2022. ISSN 1805-9619.

ŠIMONÍK, Jan; Richard ŠTEFANÍK; Pavla BOUCHALOVÁ; Petr LAPČÍK; David POTĚŠIL; Ján PODHOREC; Milan HORA; Alexandr POPRACH; Ondřej FIALA a Pavel BOUCHAL. Proteotype classification of renal cell carcinoma for prognosis and therapy response. In In Book of Abstracts of 16the Central- and Eastern European Proteomic Conference, Praha 29.9.-1.10.2022, FrO-16. 2022.